• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

淋巴瘤中重排的NFKB-2基因编码组成型活性核转录激活因子。

Rearranged NFKB-2 genes in lymphoid neoplasms code for constitutively active nuclear transactivators.

作者信息

Chang C C, Zhang J, Lombardi L, Neri A, Dalla-Favera R

机构信息

Department of Pathology, College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA.

出版信息

Mol Cell Biol. 1995 Sep;15(9):5180-7. doi: 10.1128/MCB.15.9.5180.

DOI:10.1128/MCB.15.9.5180
PMID:7651435
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC230765/
Abstract

The NFKB-2 gene codes for an NF-kappa B-related transcription factor containing rel-polyG-ankyrin domains. Chromosomal rearrangements of the NFKB-2 locus have been found in various types of lymphoid neoplasms, suggesting that they may contribute to lymphomagenesis. Rearrangements cluster within the 3'-terminal ankyrin-encoding domain of the NFKB-2 gene and lead to the production of C-terminally truncated proteins which, in some cases, are fused to heterologous protein domains. In order to determine the functional consequences of these alterations, we have analyzed the subcellular localization, DNA binding, and transcriptional activity of two representative tumor-associated mutants in which the ankyrin domain is either terminally truncated (NFKB-2p85) or truncated and joined to an out-of-frame immunoglobulin C alpha domain (lyt-10C alpha). Immunofluorescence studies performed on cells transfected with p85 or lyt-10C alpha expression vectors showed that both the abnormal proteins were constitutively localized in the nucleus. Immunoprecipitation analysis of UV-cross-linked DNA-protein adducts showed that p85 can bind kappa B sites in its unprocessed form. Cotransfection of p85 or lyt-10C alpha expression vectors with kappa B-driven reporter plasmids showed that both p85 and lyt-10C alpha have retained the ability to mediate transcriptional activation via heterodimerization with Rel-Ap65 but have lost the transrepression activity associated with homodimeric DNA binding. Furthermore, both p85 and lyt-10C alpha were capable of independent transactivation of kappa B-reporter genes and this activity could not be further stimulated by Bcl-3. These abnormal proteins may contribute to lumphomagenesis by determining a constitutive activation of the NF-kappa B system and, in particular, of NFKB-2 target genes.

摘要

NFKB - 2基因编码一种包含rel - 多聚G - 锚蛋白结构域的NF - κB相关转录因子。在各种类型的淋巴瘤中发现了NFKB - 2基因座的染色体重排,这表明它们可能参与淋巴瘤的发生。重排聚集在NFKB - 2基因的3'末端锚蛋白编码结构域内,并导致产生C末端截短的蛋白质,在某些情况下,这些蛋白质与异源蛋白结构域融合。为了确定这些改变的功能后果,我们分析了两种代表性的肿瘤相关突变体的亚细胞定位、DNA结合和转录活性,其中锚蛋白结构域要么在末端截短(NFKB - 2p85),要么截短并与框外免疫球蛋白Cα结构域连接(lyt - 10Cα)。对用p85或lyt - 10Cα表达载体转染的细胞进行的免疫荧光研究表明,这两种异常蛋白都组成性地定位于细胞核中。对紫外线交联的DNA - 蛋白质加合物的免疫沉淀分析表明,p85可以以未加工的形式结合κB位点。用κB驱动的报告质粒与p85或lyt - 10Cα表达载体共转染表明,p85和lyt - 10Cα都保留了通过与Rel - Ap65异源二聚化介导转录激活的能力,但失去了与同型二聚体DNA结合相关的反式抑制活性。此外,p85和lyt - 10Cα都能够独立激活κB报告基因,并且这种活性不能被Bcl - 3进一步刺激。这些异常蛋白可能通过确定NF - κB系统,特别是NFKB - 2靶基因的组成性激活而参与淋巴瘤的发生。

相似文献

1
Rearranged NFKB-2 genes in lymphoid neoplasms code for constitutively active nuclear transactivators.淋巴瘤中重排的NFKB-2基因编码组成型活性核转录激活因子。
Mol Cell Biol. 1995 Sep;15(9):5180-7. doi: 10.1128/MCB.15.9.5180.
2
Constitutive expression of lymphoma-associated NFKB-2/Lyt-10 proteins is tumorigenic in murine fibroblasts.淋巴瘤相关的NFKB - 2/Lyt - 10蛋白的组成型表达在小鼠成纤维细胞中具有致瘤性。
Oncogene. 1997 Apr 17;14(15):1805-10. doi: 10.1038/sj.onc.1201015.
3
Mechanism of expression and role in transcriptional control of the proto-oncogene NFKB-2/LYT-10.原癌基因NFKB - 2/LYT - 10的表达机制及其在转录调控中的作用。
Oncogene. 1994 Mar;9(3):923-33.
4
The involvement of the candidate proto-oncogene NFKB2/lyt-10 in lymphoid malignancies.候选原癌基因NFKB2/lyt-10在淋巴系统恶性肿瘤中的作用。
Leuk Lymphoma. 1996 Sep;23(1-2):43-8. doi: 10.3109/10428199609054800.
5
Rearranged NFKB2 gene in the HUT78 T-lymphoma cell line codes for a constitutively nuclear factor lacking transcriptional repressor functions.HUT78 T淋巴瘤细胞系中重排的NFKB2基因编码一种缺乏转录抑制功能的组成型核因子。
Oncogene. 1994 Jul;9(7):1931-7.
6
Heterogeneous chromosomal aberrations generate 3' truncations of the NFKB2/lyt-10 gene in lymphoid malignancies.异质性染色体畸变在淋巴恶性肿瘤中产生NFKB2/lyt-10基因的3'端截短。
Blood. 1994 Dec 1;84(11):3850-60.
7
B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-kappa B p50.B细胞淋巴瘤相关的染色体易位涉及候选癌基因lyt-10,其与核因子-κB p50同源。
Cell. 1991 Dec 20;67(6):1075-87. doi: 10.1016/0092-8674(91)90285-7.
8
Heterologous C-terminal sequences disrupt transcriptional activation and oncogenesis by p59v-rel.异源C末端序列破坏p59v-rel的转录激活和肿瘤发生。
J Virol. 1993 Dec;67(12):7161-71. doi: 10.1128/JVI.67.12.7161-7171.1993.
9
Structural alterations of the NF-kappa B transcription factor lyt-10 in lymphoid malignancies.淋巴恶性肿瘤中NF-κB转录因子lyt-10的结构改变。
Oncogene. 1993 Oct;8(10):2839-45.
10
Molecular cloning and characterization of a novel Rel/NF-kappa B family member displaying structural and functional homology to NF-kappa B p50/p105.一种与NF-κB p50/p105具有结构和功能同源性的新型Rel/NF-κB家族成员的分子克隆与鉴定
DNA Cell Biol. 1992 Sep;11(7):523-37. doi: 10.1089/dna.1992.11.523.

引用本文的文献

1
Development of RelB-targeting small-molecule inhibitors of non-canonical NF-κB signaling with antitumor efficacy.具有抗肿瘤功效的靶向RelB的非经典NF-κB信号小分子抑制剂的研发。
Mol Ther. 2025 Apr 2;33(4):1519-1534. doi: 10.1016/j.ymthe.2025.01.048. Epub 2025 Feb 4.
2
PUM1-TRAF3 fusion protein activates non-canonical NF-κB signaling via rescued NIK in biliary tract cancer.PUM1-TRAF3融合蛋白通过在胆管癌中挽救NIK来激活非经典NF-κB信号通路。
NPJ Precis Oncol. 2024 Aug 1;8(1):170. doi: 10.1038/s41698-024-00654-2.
3
NF-κB subunits direct kinetically distinct transcriptional cascades in antigen receptor-activated B cells.NF-κB 亚基在抗原受体激活的 B 细胞中指导动力学上不同的转录级联反应。
Nat Immunol. 2023 Sep;24(9):1552-1564. doi: 10.1038/s41590-023-01561-7. Epub 2023 Jul 31.
4
Transcriptional Regulation during Aberrant Activation of NF-κB Signalling in Cancer.癌症中 NF-κB 信号异常激活时的转录调控。
Cells. 2023 Mar 2;12(5):788. doi: 10.3390/cells12050788.
5
Origin of the Functional Distinctiveness of NF-κB/p52.NF-κB/p52功能独特性的起源
Front Cell Dev Biol. 2021 Nov 23;9:764164. doi: 10.3389/fcell.2021.764164. eCollection 2021.
6
PELI1 promotes radiotherapy sensitivity by inhibiting noncanonical NF-κB in esophageal squamous cancer.PELI1 通过抑制食管鳞癌细胞中非经典 NF-κB 促进放射敏感性。
Mol Oncol. 2022 Mar;16(6):1384-1401. doi: 10.1002/1878-0261.13134. Epub 2021 Nov 14.
7
Enhancing B-Cell Malignancies-On Repurposing Enhancer Activity towards Cancer.增强B细胞恶性肿瘤——关于将增强子活性重新用于癌症治疗
Cancers (Basel). 2021 Jun 29;13(13):3270. doi: 10.3390/cancers13133270.
8
Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study.针对 NF-κB 通路的疾病治疗:机制与临床研究。
Signal Transduct Target Ther. 2020 Sep 21;5(1):209. doi: 10.1038/s41392-020-00312-6.
9
Balance between NF-κB p100 and p52 regulates T cell costimulation dependence.NF-κB p100 和 p52 之间的平衡调节 T 细胞共刺激依赖性。
J Immunol. 2013 Jan 15;190(2):549-55. doi: 10.4049/jimmunol.1201697. Epub 2012 Dec 17.
10
SCF(Fbw7) modulates the NFkB signaling pathway by targeting NFkB2 for ubiquitination and destruction.SCF(Fbw7)通过靶向 NFkB2 进行泛素化和降解来调节 NFkB 信号通路。
Cell Rep. 2012 May 31;1(5):434-43. doi: 10.1016/j.celrep.2012.04.002.

本文引用的文献

1
The bcl-3 proto-oncogene encodes a nuclear I kappa B-like molecule that preferentially interacts with NF-kappa B p50 and p52 in a phosphorylation-dependent manner.bcl-3原癌基因编码一种核内类IκB分子,该分子以磷酸化依赖的方式优先与NF-κB p50和p52相互作用。
Mol Cell Biol. 1993 Jun;13(6):3557-66. doi: 10.1128/mcb.13.6.3557-3566.1993.
2
p105 and p98 precursor proteins play an active role in NF-kappa B-mediated signal transduction.p105和p98前体蛋白在核因子κB介导的信号转导中发挥积极作用。
Genes Dev. 1993 Apr;7(4):705-18. doi: 10.1101/gad.7.4.705.
3
The oncoprotein Bcl-3 directly transactivates through kappa B motifs via association with DNA-binding p50B homodimers.癌蛋白Bcl-3通过与DNA结合的p50B同型二聚体结合,直接通过κB基序进行反式激活。
Cell. 1993 Mar 12;72(5):729-39. doi: 10.1016/0092-8674(93)90401-b.
4
Conservation of transcriptional activation functions of the NF-kappa B p50 and p65 subunits in mammalian cells and Saccharomyces cerevisiae.哺乳动物细胞和酿酒酵母中NF-κB p50和p65亚基转录激活功能的保守性
Mol Cell Biol. 1993 Mar;13(3):1666-74. doi: 10.1128/mcb.13.3.1666-1674.1993.
5
Dimerization of NF-KB2 with RelA(p65) regulates DNA binding, transcriptional activation, and inhibition by an I kappa B-alpha (MAD-3).NF-KB2与RelA(p65)的二聚化通过IκB-α(MAD-3)调节DNA结合、转录激活及抑制作用。
Mol Cell Biol. 1993 Mar;13(3):1315-22. doi: 10.1128/mcb.13.3.1315-1322.1993.
6
Opposite regulation of gene transcription and cell proliferation by c-Myc and Max.c-Myc和Max对基因转录和细胞增殖的相反调节作用。
Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):2935-9. doi: 10.1073/pnas.90.7.2935.
7
Structural alterations of the NF-kappa B transcription factor lyt-10 in lymphoid malignancies.淋巴恶性肿瘤中NF-κB转录因子lyt-10的结构改变。
Oncogene. 1993 Oct;8(10):2839-45.
8
The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-kappa B p50 homodimers.候选原癌基因bcl-3编码一种转录共激活因子,该因子通过核因子κB p50同二聚体激活。
Genes Dev. 1993 Jul;7(7B):1354-63. doi: 10.1101/gad.7.7b.1354.
9
Rearranged NFKB2 gene in the HUT78 T-lymphoma cell line codes for a constitutively nuclear factor lacking transcriptional repressor functions.HUT78 T淋巴瘤细胞系中重排的NFKB2基因编码一种缺乏转录抑制功能的组成型核因子。
Oncogene. 1994 Jul;9(7):1931-7.
10
Mechanism of expression and role in transcriptional control of the proto-oncogene NFKB-2/LYT-10.原癌基因NFKB - 2/LYT - 10的表达机制及其在转录调控中的作用。
Oncogene. 1994 Mar;9(3):923-33.